COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of COVID-19 Vaccines & Therapeutics in Global, including the following market information:
Global COVID-19 Vaccines & Therapeutics Market Size 2023-2028, ($ millions)
The global COVID-19 Vaccines & Therapeutics market is projected to reach US$ million by 2028.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Vaccines & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Vaccines & Therapeutics Market, by Type, 2023-2028 ($ millions)
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Type
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Application
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, By Region and Country
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Global COVID-19 Vaccines & Therapeutics Market Size 2023-2028, ($ millions)
The global COVID-19 Vaccines & Therapeutics market is projected to reach US$ million by 2028.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Vaccines & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Vaccines & Therapeutics Market, by Type, 2023-2028 ($ millions)
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Type
- COVID-19 Vaccines
- COVID-19 Therapeutics
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Application
- Children
- Adult
Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, By Region and Country
- United States
- Europe
- Asia
- China
- Rest of World
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Moderna Therapeutics
- AstraZeneca
- Janssen
- Novavax
- Gilead Sciences
- Eli Lilly and Company
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 COVID-19 Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COVID-19 VACCINES & THERAPEUTICS OVERALL MARKET SIZE
2.1 Global COVID-19 Vaccines & Therapeutics Market Size: 2022 VS 2028
2.2 Global COVID-19 Vaccines & Therapeutics Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Key COVID-19 Vaccines & Therapeutics Players in Global Market
3.2 Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
4 PLAYERS PROFILES
4.1 Pfizer
4.1.1 Pfizer Corporate Summary
4.1.2 Pfizer Business Overview
4.1.3 Pfizer COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.1.4 Pfizer COVID-19 Vaccines & Therapeutics R&D, and Plans
4.2 Moderna Therapeutics
4.2.1 Moderna Therapeutics Corporate Summary
4.2.2 Moderna Therapeutics Business Overview
4.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.2.4 Moderna Therapeutics COVID-19 Vaccines & Therapeutics R&D, and Plans
4.3 AstraZeneca
4.3.1 AstraZeneca Corporate Summary
4.3.2 AstraZeneca Business Overview
4.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.3.4 AstraZeneca COVID-19 Vaccines & Therapeutics R&D, and Plans
4.4 Janssen
4.4.1 Janssen Corporate Summary
4.4.2 Janssen Business Overview
4.4.3 Janssen COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.4.4 Janssen COVID-19 Vaccines & Therapeutics R&D, and Plans
4.5 Novavax
4.5.1 Novavax Corporate Summary
4.5.2 Novavax Business Overview
4.5.3 Novavax COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.5.4 Novavax COVID-19 Vaccines & Therapeutics R&D, and Plans
4.6 Gilead Sciences
4.6.1 Gilead Sciences Corporate Summary
4.6.2 Gilead Sciences Business Overview
4.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.6.4 Gilead Sciences COVID-19 Vaccines & Therapeutics R&D, and Plans
4.7 Eli Lilly and Company
4.7.1 Eli Lilly and Company Corporate Summary
4.7.2 Eli Lilly and Company Business Overview
4.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.7.4 Eli Lilly and Company COVID-19 Vaccines & Therapeutics R&D, and Plans
5 SIGHTS BY REGION
5.1 By Region - Global COVID-19 Vaccines & Therapeutics Market Size, 2023 & 2028
5.2 By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of COVID-19 Vaccines & Therapeutics in United States
5.3.2 United States COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Vaccines & Therapeutics in Europe
5.4.2 Europe COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Vaccines & Therapeutics in China
5.5.2 China COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.6 Rest of World
6 SIGHTS BY PRODUCT
6.1 by Type - Global COVID-19 Vaccines & Therapeutics Market Size Markets, 2023 & 2028
6.2 COVID-19 Vaccines
6.3 COVID-19 Therapeutics
7 SIGHTS BY APPLICATION
7.1 By Application - Global COVID-19 Vaccines & Therapeutics Market Size, 2023 & 2028
7.2 Children
7.3 Adult
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 COVID-19 Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COVID-19 VACCINES & THERAPEUTICS OVERALL MARKET SIZE
2.1 Global COVID-19 Vaccines & Therapeutics Market Size: 2022 VS 2028
2.2 Global COVID-19 Vaccines & Therapeutics Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Key COVID-19 Vaccines & Therapeutics Players in Global Market
3.2 Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
4 PLAYERS PROFILES
4.1 Pfizer
4.1.1 Pfizer Corporate Summary
4.1.2 Pfizer Business Overview
4.1.3 Pfizer COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.1.4 Pfizer COVID-19 Vaccines & Therapeutics R&D, and Plans
4.2 Moderna Therapeutics
4.2.1 Moderna Therapeutics Corporate Summary
4.2.2 Moderna Therapeutics Business Overview
4.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.2.4 Moderna Therapeutics COVID-19 Vaccines & Therapeutics R&D, and Plans
4.3 AstraZeneca
4.3.1 AstraZeneca Corporate Summary
4.3.2 AstraZeneca Business Overview
4.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.3.4 AstraZeneca COVID-19 Vaccines & Therapeutics R&D, and Plans
4.4 Janssen
4.4.1 Janssen Corporate Summary
4.4.2 Janssen Business Overview
4.4.3 Janssen COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.4.4 Janssen COVID-19 Vaccines & Therapeutics R&D, and Plans
4.5 Novavax
4.5.1 Novavax Corporate Summary
4.5.2 Novavax Business Overview
4.5.3 Novavax COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.5.4 Novavax COVID-19 Vaccines & Therapeutics R&D, and Plans
4.6 Gilead Sciences
4.6.1 Gilead Sciences Corporate Summary
4.6.2 Gilead Sciences Business Overview
4.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.6.4 Gilead Sciences COVID-19 Vaccines & Therapeutics R&D, and Plans
4.7 Eli Lilly and Company
4.7.1 Eli Lilly and Company Corporate Summary
4.7.2 Eli Lilly and Company Business Overview
4.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.7.4 Eli Lilly and Company COVID-19 Vaccines & Therapeutics R&D, and Plans
5 SIGHTS BY REGION
5.1 By Region - Global COVID-19 Vaccines & Therapeutics Market Size, 2023 & 2028
5.2 By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of COVID-19 Vaccines & Therapeutics in United States
5.3.2 United States COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Vaccines & Therapeutics in Europe
5.4.2 Europe COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Vaccines & Therapeutics in China
5.5.2 China COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.6 Rest of World
6 SIGHTS BY PRODUCT
6.1 by Type - Global COVID-19 Vaccines & Therapeutics Market Size Markets, 2023 & 2028
6.2 COVID-19 Vaccines
6.3 COVID-19 Therapeutics
7 SIGHTS BY APPLICATION
7.1 By Application - Global COVID-19 Vaccines & Therapeutics Market Size, 2023 & 2028
7.2 Children
7.3 Adult
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. COVID-19 Vaccines & Therapeutics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Vaccines & Therapeutics Market Drivers in Global Market
Table 3. COVID-19 Vaccines & Therapeutics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Vaccines & Therapeutics in Global Market
Table 5. Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
Table 6. Pfizer Corporate Summary
Table 7. Pfizer COVID-19 Vaccines & Therapeutics Product Offerings
Table 8. Moderna Therapeutics Corporate Summary
Table 9. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings
Table 10. AstraZeneca Corporate Summary
Table 11. AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings
Table 12. Janssen Corporate Summary
Table 13. Janssen COVID-19 Vaccines & Therapeutics Product Offerings
Table 14. Novavax Corporate Summary
Table 15. Novavax COVID-19 Vaccines & Therapeutics Product Offerings
Table 16. Gilead Sciences Corporate Summary
Table 17. Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings
Table 18. Eli Lilly and Company Corporate Summary
Table 19. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings
Table 20. By Region– Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2023 & 2028
Table 21. By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Type – Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2023 & 2028
Table 23. By Application– Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2023 & 2028
Table 1. COVID-19 Vaccines & Therapeutics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Vaccines & Therapeutics Market Drivers in Global Market
Table 3. COVID-19 Vaccines & Therapeutics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Vaccines & Therapeutics in Global Market
Table 5. Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
Table 6. Pfizer Corporate Summary
Table 7. Pfizer COVID-19 Vaccines & Therapeutics Product Offerings
Table 8. Moderna Therapeutics Corporate Summary
Table 9. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings
Table 10. AstraZeneca Corporate Summary
Table 11. AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings
Table 12. Janssen Corporate Summary
Table 13. Janssen COVID-19 Vaccines & Therapeutics Product Offerings
Table 14. Novavax Corporate Summary
Table 15. Novavax COVID-19 Vaccines & Therapeutics Product Offerings
Table 16. Gilead Sciences Corporate Summary
Table 17. Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings
Table 18. Eli Lilly and Company Corporate Summary
Table 19. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings
Table 20. By Region– Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2023 & 2028
Table 21. By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Type – Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2023 & 2028
Table 23. By Application– Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2023 & 2028
LIST OF FIGURES
Figure 1. COVID-19 Vaccines & Therapeutics Segment by Type in 2021
Figure 2. COVID-19 Vaccines & Therapeutics Segment by Application in 2021
Figure 3. Global COVID-19 Vaccines & Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Vaccines & Therapeutics Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Vaccines & Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
Figure 8. By Type - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
Figure 9. By Application - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
Figure 1. COVID-19 Vaccines & Therapeutics Segment by Type in 2021
Figure 2. COVID-19 Vaccines & Therapeutics Segment by Application in 2021
Figure 3. Global COVID-19 Vaccines & Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Vaccines & Therapeutics Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Vaccines & Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
Figure 8. By Type - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
Figure 9. By Application - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2023-2028
